226 related articles for article (PubMed ID: 25027368)
1. In vitro methods in drug transporter interaction assessment.
Jani M; Krajcsi P
Drug Discov Today Technol; 2014 Jun; 12():e105-12. PubMed ID: 25027368
[TBL] [Abstract][Full Text] [Related]
2. EUFEPS conference on drug transporters at Copenhagen: integrative approaches in ADME research.
Meijer DK; Lennernäs H
Eur J Pharm Sci; 2005 Sep; 26(1):130-43. PubMed ID: 16161216
[No Abstract] [Full Text] [Related]
3. Transporter assays as useful in vitro tools in drug discovery and development.
Volpe DA
Expert Opin Drug Discov; 2016; 11(1):91-103. PubMed ID: 26512742
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Proposed In Vivo Probe Substrates and Inhibitors for Phenotyping Transporter Activity in Humans.
Momper JD; Tsunoda SM; Ma JD
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S82-98. PubMed ID: 27385182
[TBL] [Abstract][Full Text] [Related]
5. What do drug transporters really do?
Nigam SK
Nat Rev Drug Discov; 2015 Jan; 14(1):29-44. PubMed ID: 25475361
[TBL] [Abstract][Full Text] [Related]
6. Lack of Interactions Between an Antisense Oligonucleotide with 2'-O-(2-Methoxyethyl) Modifications and Major Drug Transporters.
Yu RZ; Warren MS; Watanabe T; Nichols B; Jahic M; Huang J; Burkey J; Geary RS; Henry SP; Wang Y
Nucleic Acid Ther; 2016 Apr; 26(2):111-7. PubMed ID: 26959999
[TBL] [Abstract][Full Text] [Related]
7. Transporter-mediated drug delivery: recent progress and experimental approaches.
Sai Y; Tsuji A
Drug Discov Today; 2004 Aug; 9(16):712-20. PubMed ID: 15341785
[TBL] [Abstract][Full Text] [Related]
8. The potential of Sutherlandia frutescens for herb-drug interaction.
Fasinu PS; Gutmann H; Schiller H; James AD; Bouic PJ; Rosenkranz B
Drug Metab Dispos; 2013 Feb; 41(2):488-97. PubMed ID: 23209194
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of membrane transporters: a review of current approaches.
Sissung TM; Gardner ER; Gao R; Figg WD
Methods Mol Biol; 2008; 448():41-62. PubMed ID: 18370230
[TBL] [Abstract][Full Text] [Related]
10. Drug transport proteins in the liver.
Faber KN; Müller M; Jansen PL
Adv Drug Deliv Rev; 2003 Jan; 55(1):107-24. PubMed ID: 12535576
[TBL] [Abstract][Full Text] [Related]
11. Quantitative transporter proteomics by liquid chromatography with tandem mass spectrometry: addressing methodologic issues of plasma membrane isolation and expression-activity relationship.
Kumar V; Prasad B; Patilea G; Gupta A; Salphati L; Evers R; Hop CE; Unadkat JD
Drug Metab Dispos; 2015 Feb; 43(2):284-8. PubMed ID: 25488931
[TBL] [Abstract][Full Text] [Related]
12. Transporter-mediated tissue targeting of therapeutic molecules in drug discovery.
Zhou J; Xu J; Huang Z; Wang M
Bioorg Med Chem Lett; 2015 Mar; 25(5):993-7. PubMed ID: 25650254
[TBL] [Abstract][Full Text] [Related]
13. The role of transporters in drug interactions.
Endres CJ; Hsiao P; Chung FS; Unadkat JD
Eur J Pharm Sci; 2006 Apr; 27(5):501-17. PubMed ID: 16364611
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Lin X; Skolnik S; Chen X; Wang J
Drug Metab Dispos; 2011 Feb; 39(2):265-74. PubMed ID: 21051535
[TBL] [Abstract][Full Text] [Related]
15. The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.
Ebner T; Ishiguro N; Taub ME
J Pharm Sci; 2015 Sep; 104(9):3220-8. PubMed ID: 25981193
[TBL] [Abstract][Full Text] [Related]
16. The need for human breast cancer resistance protein substrate and inhibition evaluation in drug discovery and development: why, when, and how?
Poirier A; Portmann R; Cascais AC; Bader U; Walter I; Ullah M; Funk C
Drug Metab Dispos; 2014 Sep; 42(9):1466-77. PubMed ID: 24989889
[TBL] [Abstract][Full Text] [Related]
17. Species differences in drug transporters and implications for translating preclinical findings to humans.
Chu X; Bleasby K; Evers R
Expert Opin Drug Metab Toxicol; 2013 Mar; 9(3):237-52. PubMed ID: 23256482
[TBL] [Abstract][Full Text] [Related]
18. In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
Reese MJ; Savina PM; Generaux GT; Tracey H; Humphreys JE; Kanaoka E; Webster LO; Harmon KA; Clarke JD; Polli JW
Drug Metab Dispos; 2013 Feb; 41(2):353-61. PubMed ID: 23132334
[TBL] [Abstract][Full Text] [Related]
19. The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions.
Kovacsics D; Patik I; Özvegy-Laczka C
Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):409-424. PubMed ID: 27783531
[TBL] [Abstract][Full Text] [Related]
20. Systems-ADME/Tox: resources and network approaches.
Ekins S
J Pharmacol Toxicol Methods; 2006; 53(1):38-66. PubMed ID: 16054403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
